We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LENALIDOMIDE VIATRIS (Alphapharm Pty Ltd)
Product name
LENALIDOMIDE VIATRIS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
117 (255 working days)
Active ingredients
Lenalidomide
Registration type
New generic medicine
Indication
LENALIDOMIDE VIATRIS is indicated for the treatment of multiple myeloma.